Vascular Improvement With Olmesartan Medoxomil Study

NCT00772499 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: olmesartan medoxomil + hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure
DRUG: atenolol+ hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure

Sponsor

Daiichi Sankyo